Churchill Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Churchill Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-28,491	Closed	-$4.03M	–	111
2016 Q2	$4.03M	Buy	+28,491	New	+$4.2M	0.26%	66
2015 Q3	–	Sell	-171,426	Closed	-$30.2M	–	157
2015 Q2	$30.2M	Sell	171,426 -20,548	-11%	-$3.69M	1.07%	23
2015 Q1	$33.2M	Sell	191,974 -71,964	-27%	-$12.4M	1.14%	24
2014 Q4	$43.2M	Sell	263,938 -65,879	-20%	-$10.9M	1.72%	17
2014 Q3	$53M	Buy	+329,817	New	+$50.7M	2.18%	16
2014 Q1	–	Sell	-12,563	Closed	-$1.59M	–	198
2013 Q4	$1.59M	Buy	12,563 +3,001	+31%	+$311K	0.06%	112
2013 Q3	$879K	Buy	+9,562	New	+$771K	0.05%	121

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Churchill Management's JAZZ Position: Q3 2016 in Review

Churchill Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2016, closing a stake of 28,491 shares — an estimated $4.03M sold.

Churchill Management first reported a position in JAZZ in Q3 2013 and held it in 7 quarters. The position peaked at $53M in Q3 2014. 325 funds tracked by Wall St. Rank hold JAZZ as of Q3 2016.

Churchill Management reported no remaining Jazz Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Churchill Management sold 28,491 Jazz Pharmaceuticals shares in Q3 2016, an estimated $4.03M.
Churchill Management first reported a position in Jazz Pharmaceuticals in Q3 2013 and held it in 7 quarters.
Churchill Management's Jazz Pharmaceuticals position peaked at $53M in Q3 2014.
325 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2016.

Based on Churchill Management's 13F filing for Q3 2016, filed 19 Oct 2016.